Loading…
Discovery of novel sesquistilbene indanone analogues as potent anti-inflammatory agents
To develop novel anti-inflammatory agents with improved pharmaceutical profiles, twenty-eight novel sesquistilbene indanone analogues were synthesized and evaluated for anti-inflammatory activity using RAW264.7 cells. Among these compounds, compound 11k was found to be one of the most potent analogu...
Saved in:
Published in: | European journal of medicinal chemistry 2016-05, Vol.113, p.63-74 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | To develop novel anti-inflammatory agents with improved pharmaceutical profiles, twenty-eight novel sesquistilbene indanone analogues were synthesized and evaluated for anti-inflammatory activity using RAW264.7 cells. Among these compounds, compound 11k was found to be one of the most potent analogues in inhibiting NO production in LPS-stimulated RAW264.7 cells. Furthermore, it could also significantly suppress LPS-induced iNOS and COX-2 expression and NO production through TLR4/JNK/NF-κB signaling pathway in a concentration dependent manner.
Sesquistilbene indanone analogue 11k was much more potent than resveratrol for its anti-inflammatory activity. It could also significantly suppress LPS-induced iNOS and COX-2 expression and NO production through TLR4/JNK/NF-κB signaling pathway in a concentration dependent manner. [Display omitted]
•Compound 11k was more effective than resveratrol.•(±)-11k, (+)-11k and (−)-11k, do not have impacts on activity and toxicity.•(±)-11k could suppress iNOS, COX-2 expression and NO production.•The mechanism of (±)-11k was through TLR4/JNK/NF-κB signaling pathway. |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2016.02.021 |